Rmr Wealth Builders Sorrento Therapeutics, Inc. Transaction History

Rmr Wealth Builders

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$1.51 - $2.88 $23,782 - $45,360	15,750 Added 64.29%	40,250 $63,000
Q2 2022 Aug 02, 2022	BUY	$1.24 - $2.33 $30,380 - $57,085	24,500 New	24,500 $49,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $1,905 - $3,000	-300 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.03 - $16.51 $2,109 - $4,953	300 New	300 $2,000
Q4 2020 Feb 09, 2021	SELL	$5.76 - $11.95 $59,328 - $123,084	-10,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $63,551 - $193,846	10,300 New	10,300 $115,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.